Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
| Active as of 2023-12-17 |
Resource Evidence "179590" Version "4" Updated "2023-12-08 13:32:44+0000"
Profile: NetEffectContribution
StructureDefinition Work Group: cds
url: https://fevir.net/resources/Evidence/179590
identifier: FEvIR Object Identifier: 179590
version: 1.0.0-ballot
name: NetEffectContribution_Treatment_with_opioids_for_Example_for_GIN_2022
title: NetEffectContribution: Treatment with opioids for Example for GIN 2022
status: active
date: 2023-12-17 16:55:23+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
author: Brian S. Alper:
| Code | Value[x] |
| Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | ComparativeEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#ComparativeEvidence) |
| Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | NetEffectContribution (Evidence Based Medicine on FHIR Implementation Guide Code System#NetEffectContribution) |
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
| Type | Citation | ResourceReference |
| cite-as | NetEffectContribution: Treatment with opioids for Example for GIN 2022 [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179590. Revised 2023-12-04. Available at: https://fevir.net/resources/Evidence/179590. Computable resource at: https://fevir.net/resources/Evidence/179590. | |
| amended-with | ArtifactAssessment/104195: Outcome Importance Rating (default value 5) of Treatment with opioids |
description: -0.24 (-0.32 to -0.16)
variableDefinition
VariableDefinitionVariableRoleCode: population
description: Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included).
note: population
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#population "population")
observed: Group/178427: StudyGroup: Severely Obese Adults 2018 Norwegian Cohort "Severely_Obese_Adults_2018_Norwegian_Cohort"
variableDefinition
VariableDefinitionVariableRoleCode: exposure
VariableDefinitionComparatorCategory: no bariatric surgery
description: comparison groups of bariatric surgery vs. no bariatric surgery
note: exposure
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#exposure "exposure")
observed: EvidenceVariable/172427: GroupAssignment: Bariatric Surgery vs. no bariatric surgery "GroupAssignment_Bariatric_Surgery_vs_no_bariatric_surgery"
variableDefinition
VariableDefinitionVariableRoleCode: outcome
description: Treatment with opioids
note: outcome
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#measuredVariable "measured variable")
observed: EvidenceVariable/104119: OutcomeVariable: Treatment with opioids "OutcomeVariable_Treatment_with_opioids"
variableDefinition
VariableDefinitionVariableRoleCode: covariate
VariableDefinitionRoleSubtype: Relative importance multiplier (Evidence Based Medicine on FHIR Implementation Guide Code System#importance-multiplier)
description: Relative Importance Multiplier
note: covariate
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#confounder "confounder")
observed: : Relative Importance Multiplier
statistic
description: risk difference -0.24 (95% CI -0.32 to -0.16)
statisticType: Risk Difference (Scientific Evidence Code System (SEVCO) -- EXAMPLE VERSION for EBMonFHIR Implementation Guide#STATO:0000424)
quantity: -0.24
AttributeEstimates
Description Type Level Range 95% CI -0.32 to -0.16 confidence interval (Scientific Evidence Code System (SEVCO) -- EXAMPLE VERSION for EBMonFHIR Implementation Guide#STATO:0000196) 0.95 -0.32--0.16 ModelCharacteristics
Code Net effect contribution analysis (Scientific Evidence Code System (SEVCO) -- EXAMPLE VERSION for EBMonFHIR Implementation Guide#TBD:net-effect-contribution-analysis)
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change